Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05929885
Status:
RECRUITING
Last Update Posted:
2024-01-03
First Post:
2023-04-24
Brief Title:
Metronomic Capecitabine Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
Sponsor:
National Cancer Centre Singapore
Organization:
National Cancer Centre Singapore
Organization Data
Organization:
National Cancer Centre Singapore
Class:
OTHER
Study ID:
LDOXIRI-PDAC-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Centre Singapore
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Medical Research Council NMRC Singapore | OTHER_GOV |